Article
Insulin-like growth factor binding protein-3 generation as a measure of GH sensitivity.
The Journal of clinical endocrinology and metabolism - 1 Oct 2002
Buckway C K, Selva K A, Pratt K L, Tjoeng E, Guevara-Aguirre J, Rosenfeld R G
Abstract excerpt
A total of 198 subjects were randomized to either high-dose (0.05 mg/kg.d) or low-dose (0.025 mg/kg.d) GH for 7 d; the alternate dose was then received after a 2-wk washout period. Groups included in the study were: normal, GH-insensitive (GHI; homozygous for the E180 splice mutation); heterozygous GHI (carriers of the E180 splice mutation); GH-deficient; and idiopathic short stature. Serum IGF binding protein-3...
Topics
- Adolescent
- Adult
- Body Height
- Child
- Drug Resistance
- Female
- Heterozygote
- Human Growth Hormone
- Humans
- Insulin-Like Growth Factor Binding Protein 3
- Insulin-Like Growth Factor I
